This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting inflammatory and autoimmune diseases, particularly those involving the modulation of specific enzymes or receptors. Its unique structure, featuring a difluoromethoxy group and a cyclopropane ring, contributes to its biological activity and stability, making it valuable for medicinal chemistry research. Additionally, it is studied for its potential applications in creating novel therapeutic agents with improved efficacy and reduced side effects.